Latest Breaking News On - At moln ch0256379097 - Page 1 : vimarsana.com

Molecular Partners Shares New Preclinical Data from its AML-Focused CD3 T-Cell Engager Program, CD40 Product Candidate MP0317, and Other Novel Immuno-oncology Approaches at AACR . | April 11, 2021

United statesShai biranProdrug darpinSeth lewisThomas schneckenburgerDaniel steinerEngager programAmerican association for cancer researchResearch of molecular partnersCompany on twitter at molecularprtnrsMolecular partners shares new preclinical dataCell engager programAmerican associationCancer researchMolecular partnersScientific presentations